Advantage 40 Spot-on solution for Cats

Pajjiż: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ingredjent attiv:

Imidacloprid

Disponibbli minn:

Bayer Limited

Kodiċi ATC:

QP53AX17

INN (Isem Internazzjonali):

Imidacloprid

Dożaġġ:

40 mg/pipette

Għamla farmaċewtika:

Spot-on solution

Tip ta 'preskrizzjoni:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupp terapewtiku:

Cats

Żona terapewtika:

imidacloprid

Indikazzjonijiet terapewtiċi:

Ectoparasiticide

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2001-02-23

Karatteristiċi tal-prodott

Health Products Regulatory Authority
19 December 2017
CRN000WFR
Page 1 of 7
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 40 Spot-on solution for Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
QUANTITY:
Imidacloprid
40
mg/pipette
(0.4 ml of a 10 % solution)
EXCIPIENT(S):
Butylhydroxytoluene (E 321)
0.4
mg/pipette
For a full list f excipients, see
section 6.1
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear yellow to slightly brownish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of flea infestations on cats of less
than 4 kg body
weight.
For cats of 4 kg body weight and greater use Advantage 80 for Cats
One treatment prevents further flea infestation for three to four
weeks.
The product can be used as part of a treatment strategy for the
control of Flea
Allergy Dermatitis (FAD) where this has been previously diagnosed by a
veterinary
surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use in animals that are known to be hypersensitive to the
active substance or
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Health Products Regulatory Authority
19 December 2017
CRN000WFR
Page 2 of 7
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
This product is for topical use and should not be administered orally.
Care should be taken to avoid the contents of the pipette coming into
contact with
the eyes or mouth of the recipient animal.
Do not allow recently treated animals to groom each other.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS:
Wash hands thoroughly after use.
Wash off any skin contamination with soap and water.
People with known skin sensitivity may be particularly sensitive to
this product.
Avoid contact of the product with the eyes or mouth.
If the product gets into eyes accidentally, the eyes should be
thoroughly flushed with
water. If ski